ResearcherZhongda Hospital Southeast UniversityNo recent work listed
Min Zhou
Matched on ORCID iD 0000-0002-8022-1692; OpenAlex author ID A5026927881. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers
Papers 6
- Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition. Co-author DOI 10.1016/j.ebiom.2022.104352↗
- LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation. Co-author DOI 10.1186/s13046-022-02491-2↗
- Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cell… Co-author DOI 10.7150/ijbs.49514↗
- Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-3924. Co-author DOI 10.1038/s41419-019-2123-y↗
- Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma. Co-author DOI 10.18632/oncotarget.24443↗
- Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cells. Co-author DOI 10.3892/or.2014.3613↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shutao Pan · 5 shared papers, 2018–2022 · strength 0.54
- Paper LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to … DOI 10.1186/s13046-022-02491-2↗
- Paper Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inh… DOI 10.1016/j.ebiom.2022.104352↗
- Paper Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplat… DOI 10.7150/ijbs.49514↗
- Min Wang · 5 shared papers, 2018–2022 · strength 0.54
- Paper LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to … DOI 10.1186/s13046-022-02491-2↗
- Paper Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inh… DOI 10.1016/j.ebiom.2022.104352↗
- Paper Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplat… DOI 10.7150/ijbs.49514↗
- Renyi Qin · 5 shared papers, 2018–2022 · strength 0.54
- Paper LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to … DOI 10.1186/s13046-022-02491-2↗
- Paper Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inh… DOI 10.1016/j.ebiom.2022.104352↗
- Paper Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplat… DOI 10.7150/ijbs.49514↗
- Xingjun Guo · 4 shared papers, 2018–2022 · strength 0.42
- Paper LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to … DOI 10.1186/s13046-022-02491-2↗
- Paper Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inh… DOI 10.1016/j.ebiom.2022.104352↗
- Paper Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-39… DOI 10.1038/s41419-019-2123-y↗
- Xiuhui Shi · 4 shared papers, 2018–2022 · strength 0.41
- Paper Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inh… DOI 10.1016/j.ebiom.2022.104352↗
- Paper Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplat… DOI 10.7150/ijbs.49514↗
- Paper Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-39… DOI 10.1038/s41419-019-2123-y↗
- Ruizhi He · 4 shared papers, 2018–2022 · strength 0.41
- Paper Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inh… DOI 10.1016/j.ebiom.2022.104352↗
- Paper Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplat… DOI 10.7150/ijbs.49514↗
- Paper Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-39… DOI 10.1038/s41419-019-2123-y↗
- Chunle Zhao · 3 shared papers, 2021–2022 · strength 0.37
- Paper LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to … DOI 10.1186/s13046-022-02491-2↗
- Paper Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inh… DOI 10.1016/j.ebiom.2022.104352↗
- Paper Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplat… DOI 10.7150/ijbs.49514↗
- Taoyuan Yin · 3 shared papers, 2019–2022 · strength 0.35
- Paper LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to … DOI 10.1186/s13046-022-02491-2↗
- Paper Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inh… DOI 10.1016/j.ebiom.2022.104352↗
- Paper Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-39… DOI 10.1038/s41419-019-2123-y↗
- Yuhui Liu · 2 shared papers, 2021–2022 · strength 0.24
- Paper Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inh… DOI 10.1016/j.ebiom.2022.104352↗
- Paper Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplat… DOI 10.7150/ijbs.49514↗
- Yan Zhao · 2 shared papers, 2018–2022 · strength 0.19
- Xu Li · 2 shared papers, 2018–2022 · strength 0.19
- Zhenxiong Zhang · 1 shared paper, 2022 · strength 0.13
- Jun Gong · 1 shared paper, 2022 · strength 0.13
- Yongkang Shi · 1 shared paper, 2022 · strength 0.13
- Yuqing Zhang · 1 shared paper, 2022 · strength 0.12
- Min Li · 1 shared paper, 2022 · strength 0.12
- Zhijun Zhou · 1 shared paper, 2022 · strength 0.12
- Jingxuan Yang · 1 shared paper, 2022 · strength 0.12
- Mingyang Liu · 1 shared paper, 2022 · strength 0.12
- Li Xu · 1 shared paper, 2021 · strength 0.12
- Chengjian Shi · 1 shared paper, 2021 · strength 0.12
- Shuo Yu · 1 shared paper, 2018 · strength 0.08
- Zongdao Rui · 1 shared paper, 2015 · strength 0.05
- Chunyan Li · 1 shared paper, 2015 · strength 0.05
- Cailian Wang · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.